UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 35

Sortiert nach

CSPG4 in cancer: multiple roles

Current molecular medicine, 2010-06, Vol.10 (4), p.419

2010

Link zum Volltext

Verfügbarkeit prüfen

AB0196 Expression of the Transcription Factor Forkhead Box E3 (FOXE3) in Monocytes from Patients with Systemic Sclerosis and Correlation with their Serological Profile

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.868-868

2014

Link zum Volltext

Verfügbarkeit prüfen

Effects of adjuvants for human use in systemic lupus erythematosus (SLE)‐prone (New Zealand black/New Zealand white) F1 mice

Clinical and experimental immunology, 2014-01, Vol.175 (1), p.32-40

2014

Link zum Volltext

Verfügbarkeit prüfen

Clinical correlates of human leucocyte antigen (HLA)-G in systemic sclerosis

Clinical and experimental immunology, 2015-07, Vol.181 (1), p.100-109

2015

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of the influence of social, demographic, environmental, work-related factors and/or lifestyle habits on Raynaud’s phenomenon: a case–control study

Clinical and experimental medicine, 2020-02, Vol.20 (1), p.31-37

2020

Link zum Volltext

Verfügbarkeit prüfen

AB0695 Subspecificities of Anti-Centromeric-Associated Protein a (CENP-A) Antibodies (AB) Can Identified a Subset of Patients at Higher Risk of Developing Pulmonary Hypertension

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.1130-1130

2015

Link zum Volltext

Verfügbarkeit prüfen

Clinical correlates of human leucocyte antigen (HLA)‐G in systemic sclerosis1

Clinical and experimental immunology, 2015-07, Vol.181 (1), p.100-109

2015

Link zum Volltext

Verfügbarkeit prüfen

Raynaud's phenomenon: From molecular pathogenesis to therapy

Autoimmunity reviews, 2014-06, Vol.13 (6), p.655-667

2014

Link zum Volltext

Verfügbarkeit prüfen

HLA class I downregulation is associated with enhanced NK‐cell killing of melanoma cells with acquired drug resistance to BRAF inhibitors

European journal of immunology, 2016-02, Vol.46 (2), p.409-419

2016

Link zum Volltext

Verfügbarkeit prüfen

Biological therapy with monoclonal antibodies: a novel treatment approach to autoimmune disease

Clinical and experimental medicine, 2005-12, Vol.5 (4), p.141-160

2005

Link zum Volltext

Verfügbarkeit prüfen

Generation of biologically active linear and cyclic peptides has revealed a unique fine specificity of rituximab and its possible cross-reactivity with acid sphingomyelinase-like phosphodiesterase 3b precursor

Blood, 2006-02, Vol.107 (3), p.1070-1077

2006

Link zum Volltext

Verfügbarkeit prüfen

Clinical correlates of human leucocyte antigen (HLA)-G in systemic sclerosis super(1)

Clinical and experimental immunology, 2015-07, Vol.181 (1), p.100-109

2015

Link zum Volltext

Verfügbarkeit prüfen

B2-M-FREE HEAVY CHAIN LEVELS OF HLA-CLASS I ANTIGEN COMBINED WITH SERUM IGM OR PLATELET COUNT PROVIDE TWO RELIABLE STAGING SYSTEMS IN MULTIPLE MYELOMA

European journal of internal medicine, 2008, Vol.19, p.S15-S16

2008

Link zum Volltext

Verfügbarkeit prüfen

Phlegmonous abscess associated with etanercept therapy

Panminerva medica, 2006-09, Vol.48 (3), p.199

2006

Link zum Volltext

Verfügbarkeit prüfen

CD20: A target antigen for immunotherapy of autoimmune diseases

Autoimmunity reviews, 2005-11, Vol.4 (8), p.526-531

2005

Link zum Volltext

Verfügbarkeit prüfen

Grp94-specific monoclonal antibody to counteract BRAF inhibitor resistance in BRAFV600E melanoma

Journal of translational medicine, 2015-01, Vol.13 (S1), p.K12-K12, Article K12

2015

Link zum Volltext

Verfügbarkeit prüfen

Low mortality rate in Italian rheumatoid arthritis patients from a tertiary center: putative implication of a low anti-carbamylated protein antibodies prevalence

Open access rheumatology: research and reviews, 2018-01, Vol.10, p.129-134

2018

Link zum Volltext

Verfügbarkeit prüfen

Staging multiple myeloma patients with active disease using serum levels of β2m-free HLA class I heavy chain together with IgM or platelet count

Blood cells, molecules, & diseases, 2009, Vol.42 (1), p.71-76

2009

Link zum Volltext

Verfügbarkeit prüfen

CD20 Mimicry by a mAb Rituximab-Specific Linear Peptide: A Potential Tool for Active Immunotherapy of Autoimmune Diseases

Annals of the New York Academy of Sciences, 2005-06, Vol.1051 (1), p.672-683

2005

Link zum Volltext

Verfügbarkeit prüfen

Human CD4 mimicry by anti-idiotypic monoclonal antibody 16D7 is based on a conformational epitope

Immunology letters, 2004-09, Vol.95 (2), p.145-153

2004

Link zum Volltext

Verfügbarkeit prüfen

beta sub(2)-Microglobulin-Free HLA Class I Heavy Chain Epitope Mimicry by Monoclonal Antibody HC-10-Specific Peptide

The Journal of immunology (1950), 2003-08, Vol.171 (4), p.1918-1926

2003

Link zum Volltext

Verfügbarkeit prüfen

Evaluating scenarios toward zero plastic pollution

Science (American Association for the Advancement of Science), 2020-09, Vol.369 (6510), p.1455-1461

2020

Link zum Volltext

Verfügbarkeit prüfen

Autoantibodies recognizing the amino terminal 1-17 segment of CENP-A display unique specificities in systemic sclerosis

PloS one, 2013-04, Vol.8 (4), p.e61453-e61453

2013

Link zum Volltext

Verfügbarkeit prüfen

Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation

Blood, 2009-08, Vol.114 (7), p.1437-1444

2009

Link zum Volltext

Verfügbarkeit prüfen

Formation of anti–platelet factor 4/heparin antibodies after cardiac surgery: Influence of perioperative platelet activation, the inflammatory response, and histocompatibility leukocyte antigen status

The Journal of thoracic and cardiovascular surgery, 2008-12, Vol.136 (6), p.1456-1463

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(35)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(22)
Science & Technology
(17)
Life Sciences & Biomedicine
(15)
Female
(13)
Animals
(8)
Immunotherapy
(8)
Immunology
(7)
Male
(7)
Adult
(6)
Antibodies, Monoclonal - Therapeutic Use
(5)
Middle Aged
(5)
Peptide
(5)
Mice
(4)
Systemic Sclerosis
(4)
T-Lymphocytes - Immunology
(4)
Aged
(3)
Antigens
(3)
Antigens, Cd20 - Immunology
(3)
Autoantibodies
(3)
Autoimmune Disease
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

CSPG4 in cancer: multiple roles

AB0196 Expression of the Transcription Factor Forkhead Box E3 (FOXE3) in Monocytes from Patients with Systemic Sclerosis and Correlation with their Serological Profile

Effects of adjuvants for human use in systemic lupus erythematosus (SLE)‐prone (New Zealand black/New Zealand white) F1 mice

Clinical correlates of human leucocyte antigen (HLA)-G in systemic sclerosis

Evaluation of the influence of social, demographic, environmental, work-related factors and/or lifestyle habits on Raynaud’s phenomenon: a case–control study

AB0695 Subspecificities of Anti-Centromeric-Associated Protein a (CENP-A) Antibodies (AB) Can Identified a Subset of Patients at Higher Risk of Developing Pulmonary Hypertension

Clinical correlates of human leucocyte antigen (HLA)‐G in systemic sclerosis1

Raynaud's phenomenon: From molecular pathogenesis to therapy

HLA class I downregulation is associated with enhanced NK‐cell killing of melanoma cells with acquired drug resistance to BRAF inhibitors

Biological therapy with monoclonal antibodies: a novel treatment approach to autoimmune disease

Generation of biologically active linear and cyclic peptides has revealed a unique fine specificity of rituximab and its possible cross-reactivity with acid sphingomyelinase-like phosphodiesterase 3b precursor

Clinical correlates of human leucocyte antigen (HLA)-G in systemic sclerosis super(1)

B2-M-FREE HEAVY CHAIN LEVELS OF HLA-CLASS I ANTIGEN COMBINED WITH SERUM IGM OR PLATELET COUNT PROVIDE TWO RELIABLE STAGING SYSTEMS IN MULTIPLE MYELOMA

Phlegmonous abscess associated with etanercept therapy

CD20: A target antigen for immunotherapy of autoimmune diseases

Grp94-specific monoclonal antibody to counteract BRAF inhibitor resistance in BRAFV600E melanoma

Low mortality rate in Italian rheumatoid arthritis patients from a tertiary center: putative implication of a low anti-carbamylated protein antibodies prevalence

Staging multiple myeloma patients with active disease using serum levels of β2m-free HLA class I heavy chain together with IgM or platelet count

CD20 Mimicry by a mAb Rituximab-Specific Linear Peptide: A Potential Tool for Active Immunotherapy of Autoimmune Diseases

Human CD4 mimicry by anti-idiotypic monoclonal antibody 16D7 is based on a conformational epitope

beta sub(2)-Microglobulin-Free HLA Class I Heavy Chain Epitope Mimicry by Monoclonal Antibody HC-10-Specific Peptide

Evaluating scenarios toward zero plastic pollution

Autoantibodies recognizing the amino terminal 1-17 segment of CENP-A display unique specificities in systemic sclerosis

Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation

Formation of anti–platelet factor 4/heparin antibodies after cardiac surgery: Influence of perioperative platelet activation, the inflammatory response, and histocompatibility leukocyte antigen status

Suchergebnisse filtern